Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
NO doubt in my mind that DUncan will look after himself and push for a mark 2 brand new company with himself at the helm new share options etc , the going concern. Will he care about other investors? Who knows but they need to get organised imv unless they want to watch others snatch the value here, unopposed.
@Thunks
That actually makes perfect sense now.
I posted here to say i thought he called the Investor event because he was expecting news to tell us. We knew he was in talks with Oxford a few weeks back so maybe he did genuinely believe they would support the business and he would be telling us this at the investor event. Had that been the case the SP would have jumped and next week he would be doing a placing for 2023 and job done.
Didn't work out that way hence why he was in shock at the event with nothing to say.
They spell out the fact that one day they talked with Oxford and the next they wanted the money back. Duncan may have known before but we'll never know that. Essentially, they are in a scramble now to find someone that thinks there is value here. Plenty do and there is plenty of evidence to suggest that they are onto something from a treatment perspective. Just depends on whether someone is willing to stump up the cash and commit to support. Or perhaps buy them out relatively cheaply. The wording of that RNS does not suggest to me that its all over yet but we'll have to wait to see.
What was that investor event all about? Why was it arranged? Maybe Duncan thought he had some news to release but Oxford pulled the plug last minute?
Not to mention Blautix and the FDA, so much here... must be some decent value...
Not calculated my loss on this one yet but would imagine its about £160k. I am hoping that a buyer can be found and it gives SH a return so i can at least reduce that loss some.
The AIM market at times can be a nightmare. My 2021 trading year was damaged by a big loss on NCYT in the end i got that down to about £125k so this loss trumps that and hits my 2022 trading year and we are only in June. At times makes you want to give up....
Good luck all for next week, think we are going to need it...
''The Board intends to work with the Joint Administrators on proposals to rescue the Company as a going concern, albeit there can be no guarantee that this will be successful.''
Its 'only' $13m. In the grand scheme that's not much. Additional funding would obviously be required for continued research/operation.
Yes, any II buyer, such as Merck potentially, would no doubt use the situation to their great advantage and offer low, but there are possibilities. Oxford, for whatever reason, want their money back, no doubt not helped by Duncan's investor event performance. Biotech is back on the up so there may be more interest now. Do Merck want to take the chance of someone else buying this in admin? Who knows. There is plenty of value (IP/research/expertise/production) left in this company. Definitely not clutching at straws, in my mind the money has gone, just my own thoughts, nothing more.
It needs a good Shag, Shareholder Action Group.
ANyone got the motivation to get one organised?
$13.86m is the debt to Oxford. No idea what will happen to our money and shares, likely lost of course but that amount is not unachievable. What value does Merck put on their ongoing research for example. Hard to see positives as there are few but there may be a light at the end of the tunnel somewhere. It’s hard but don’t give up all hope yet.
Have drank a lot tonight.....absolutely gutted for us all.
But Tomorrow is another day. Grr.
Well I am in the same boat too with hefty losses in both Synairgen and 4D. I started investing in AIM stocks two years back. Second half of 2020 and first half of 2021 was brilliant, made almost 40% return. Since then just been in a downward spiral and have lost not just the 40% gains but also all the profits I had additionally made before I got onto investing in the AIM stocks from holding high quality investment funds which I had divested away from.
Last six months have been nothing but stressful seeing my portfolio bleed everyday. Two days back the value of my ISA portfolio reached the same value as what I have added each year so far ever to my ISA. Had enough that morning and at the risk of losing further money and for the sake of my own sanity, I gave up and sold all my 20 or so AIM stocks including 4D for which I booked a 85% loss as my average was around 100p.
I was at least lucky to salvage a small amount back from 4D but I really feel for all investors who kept the faith. Even after selling 4D I had thought to myself this was going to be one star which I might regret selling someday. Unfortunately taking on debt with no income stream has really killed it.
I can’t agree more, I spent the last 3 years researching companies to invest in. I have most my money in boring index funds, but of my fun money, I put the majority in Synairgen, and some in 4D… well, even when you think all the stars are aligned, you never know what will happen.
What I learnt from Synairgen, don’t invest in a company with only one product
What I learnt from 4D, avoid companies with debt? I don’t know, still working this one out.
Partnered with a major pharma, drugs which I believed were the future, good trial results… shocking really.
I am a long term invested that could have and in hindsight should have taken my profit.
The reason I didn’t is because of all of my portfolio,
This is the one I did most research on and the one I had the most belief in.
I’m so sad that it’s ended like this.
Point being.
No matter how much you believe, how much research you do.
It can all come and bite you in the arse.
Gutted.